Log in to save to my catalogue

Determinants of the outcomes of patients with cancer infected with SARS-CoV-2: results from the Gust...

Determinants of the outcomes of patients with cancer infected with SARS-CoV-2: results from the Gust...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2626016259

Determinants of the outcomes of patients with cancer infected with SARS-CoV-2: results from the Gustave Roussy cohort

Publication information

Publisher

England: Nature Publishing Group

More information

Scope and Contents

Contents

Patients with cancer are presumed to be at increased risk of severe COVID-19 outcomes due to underlying malignancy and treatment-induced immunosuppression. Of the first 178 patients managed for COVID-19 at the Gustave Roussy Cancer Centre, 125 (70.2%) were hospitalized, 47 (26.4%) developed clinical worsening and 31 (17.4%) died. An age of over 70...

Alternative Titles

Full title

Determinants of the outcomes of patients with cancer infected with SARS-CoV-2: results from the Gustave Roussy cohort

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2626016259

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2626016259

Other Identifiers

ISSN

2662-1347

E-ISSN

2662-1347

DOI

10.1038/s43018-020-00120-5

How to access this item